Sonnet Biotherapeutics Correlations
SONN Stock | USD 1.31 0.02 1.50% |
The current 90-days correlation between Sonnet Biotherapeutics and Allarity Therapeutics is 0.3 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sonnet Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sonnet Biotherapeutics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Sonnet Biotherapeutics Correlation With Market
Average diversification
The correlation between Sonnet Biotherapeutics Holding and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and DJI in the same portfolio, assuming nothing else is changed.
Sonnet |
Moving together with Sonnet Stock
0.68 | CDIOW | Cardio Diagnostics | PairCorr |
0.66 | SCLX | Scilex Holding | PairCorr |
0.67 | ASMB | Assembly Biosciences | PairCorr |
0.66 | CMND | Clearmind Medicine Common | PairCorr |
0.64 | MLSS | Milestone Scientific | PairCorr |
0.72 | CAT | Caterpillar | PairCorr |
0.69 | HD | Home Depot | PairCorr |
0.64 | DIS | Walt Disney | PairCorr |
0.68 | MSFT | Microsoft | PairCorr |
Moving against Sonnet Stock
0.61 | LUCD | Lucid Diagnostics | PairCorr |
0.44 | WM | Waste Management | PairCorr |
0.33 | PG | Procter Gamble Sell-off Trend | PairCorr |
0.57 | JNJ | Johnson Johnson | PairCorr |
0.56 | T | ATT Inc Sell-off Trend | PairCorr |
0.46 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
0.43 | INTC | Intel | PairCorr |
0.36 | IBM | International Business | PairCorr |
0.34 | CVX | Chevron Corp Sell-off Trend | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sonnet Stock performing well and Sonnet Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sonnet Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
YS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ZVSA | 4.55 | (0.74) | 0.00 | (1.60) | 0.00 | 10.11 | 38.26 | |||
ALLR | 5.52 | 0.23 | 0.03 | 0.13 | 6.20 | 13.24 | 47.01 | |||
KRBP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
IMMX | 2.95 | (0.41) | 0.00 | (0.46) | 0.00 | 6.77 | 21.65 | |||
CNSP | 7.26 | (1.55) | 0.00 | (2.34) | 0.00 | 12.10 | 81.40 | |||
EFTR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
NAVB | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sonnet Biotherapeutics Corporate Management
Manuel Dafonseca | Head Operations | Profile | |
Stephen McAndrew | Senior Development | Profile | |
Gael Hedou | Chief Officer | Profile | |
John Cini | Chief CoFounder | Profile | |
MD FACP | Chief Officer | Profile |